Biotech News

Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office

Dermata Therapeutics (DRMA)Dermata TherapeuticsCompany update

DRMA (DRMA) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is drma.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

Dermata Therapeutics

Consumer Skincare Company Dermata Therapeutics has shifted from clinical-stage dermatology development toward a direct-to-consumer commercial skincare strategy. Tome Brand Tome is designed as a professional-style at-home skincare line built around simplified, periodic treatments rather than multi-step daily regimens. Foundational...

Recent company news

Stock data

Close
1.11 USD
Market cap
5.47M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States